Reference
Cohen S, et al. Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer. Journal of Ovarian Research 12: 36, No. 1, 25 Apr 2019. Available from: URL: http://doi.org/10.1186/s13048-019-0506-4 - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1755, 39 (2019). https://doi.org/10.1007/s40278-019-62593-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62593-4